retatrutide reviews UK 2026: Phase 3 Results HeartBrief: Retatrutide Results, Food Risks,
Description
Panganiban, MD , director of the Non-Alcoholic Fatty Liver Disease Program at Childrens Hospital of Philadelphia, told Healio
The rising popularity of GLP-1 receptor agonists (GLP-1s) for weight management and type 2 diabetes mellitus (T2DM) has led to increased demand, often exceeding supply
Semaglutide and Tirzepatide show the most promising results, while options like Liraglutide and Exenatide remain valuable for their safety and efficacy
Journal of Dermatology
But the maintenance phase is different, and it should not be treated as a weaker version of the weight-loss phase
doi: 10.1038/s41443-025-01061-2
